| C8A |
C8A: Complement component C8 alpha chain precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
CYP2B6 |
CYP2B6: Cytochrome P450 2B6 |
0.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| C4BPA |
C4BPA, C4BP: C4b-binding protein alpha chain precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
PON3 |
PON3: Serum paraoxonase/lactonase 3 |
0.307 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
COL16A1 |
COL16A1: Collagen alpha-1(XVI) chain precursor |
0.307 |
Evidence |
|
| CXCL12 |
Stromal cell-derived factor 1 delta |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.307 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.307 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.307 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.307 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.307 |
Evidence |
|
| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| CDH17 |
CDH17: Cadherin-17 precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.307 |
Evidence |
|
| CDH17 |
CDH17: Cadherin-17 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.307 |
Evidence |
|
| TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.307 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.307 |
Evidence |
|
| CRYBA2 |
CRYBA2: Beta-crystallin A2 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
0.307 |
Evidence |
|